Patents-Review.com
ClassID:

21202 ⎘

A61K2039/55588 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant Adjuvants of undefined constitution

Sub-classes:
Recent Application in this class:
#1
20260151478
2026-06-04

Single Domain Anti-CD169 Antibodies

 #2
20260151351
2026-06-04

CANCER VACCINES

 #3
20260137770
2026-05-21

METHOD FOR CONSTRUCTING CIRCULAR RNA AND VACCINE AGAINST FIPV

 #4
20260130976
2026-05-14

NOVEL TUMOR-SPECIFIC ANTIGENS FOR MYELOID LEUKEMIA AND USES THEREOF

 #5
20260116918
2026-04-30

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS

 #6
20260102477
2026-04-16

Tumor-Associated Antigen Based Cancer Vaccine

 #7
20260000785
2026-01-01

INJECTABLE HYDROGELS FOR CONTROLLED RELEASE OF IMMUNOMODULATORY COMPOUNDS

 #8
20260000752
2026-01-01

ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND METHODS OF USE

 #9
20250360188
2025-11-27

MYCOPLASMA HYOPNEUMONIAE SUBUNIT VACCINE AND PREPARATION METHOD AND USE THEREOF

 #10
20250352598
2025-11-20

Improved Therapeutic Index of Anti-Immune Checkpoint Inhibitors Using Combination Therapy Comprising A PHY906 Extract, A Scutellaria baicalensis Georgi (S) Extract or A Compound From Such Extracts

 #11
20250281636
2025-09-11

CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF

 #12
20250269001
2025-08-28

METHODS TO STIMULATE IMMUNE RESPONSES TO MUTANT RAS USING ANUCLEATE CELLS

 #13
20240382576
2024-11-21

COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF

 #14
20240350419
2024-10-24

ORAL ROOM-TEMPERATURE STABLE YEAST PARTICLES (YP) AND METHODS OF USE

 #15
20240344147
2024-10-17

Methods and Materials for Using Measles Viruses

 #16
20240316168
2024-09-26

Immunomodulatory Therapy For Type 1 Diabetes Mellitus Autoimmunity

 #17
20240261397
2024-08-08

IMMUNE PREPARATION, COMPOSITION COMPRISING IMMUNE PREPARATION AND USE THEREOF, AND PREPARATION METHOD

 #18
20240252627
2024-08-01

MESENCHYMAL STEM CELLS AS VACCINE ADJUVANTS AND METHODS FOR USING THE SAME

 #19
20240238203
2024-07-18

USE OF CELLULAR MICROPARTICLES IN TREATMENT OF RESPIRATORY VIRAL PNEUMONIA

 #20
20240058438
2024-02-22

Hepatitis C virus immunogenic compositions and methods of use thereof

 #21
20240016921
2024-01-18

ANTIGEN SPECIFIC IMMUNOTHERAPY FOR COVID-19 FUSION PROTEINS AND METHODS OF USE

 #22
20230348548
2023-11-02

MEMBRANE-BOUND IL-15, CD8 POLYPEPTIDES, CELLS, COMPOSITIONS, AND METHODS OF USING THEREOF

 #23
20230338498
2023-10-26

Compositions comprising polysaccharide-protein conjugates and methods of use thereof

 #24
20230331797
2023-10-19

HLA-A24 AGONIST EPITOPES OF MUC1-C ONCOPROTEIN AND COMPOSITIONS AND METHODS OF USE

 #25
20230330219
2023-10-19

NUCLEIC ACID NANOSTRUCTURE PLATFORM FOR PROGRAMMING IMMUNE STIMULATION

 #26
20230277644
2023-09-07

COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF

 #27
20230210989
2023-07-06

Monoclonal Antibody Against Human Siglec-9 and Use For Immunotherapy

 #28
20230181645
2023-06-15

METHOD TO IMPROVE CANCER VACCINES

 #29
20230173065
2023-06-08

COMPOSITION FOR ENHANCING IMMUNE RESPONSE BY USING ACTIVATION FUNCTION OF DENDRITIC CELLS OF STROMAL VASCULAR FRACTIONS ISOLATED FROM ADIPOSE TISSUES

 #30
20230051860
2023-02-16

COMBINATION IMMUNOTHERAPIES FOR TREATMENT OF CANCER

 #31
20220401541
2022-12-22

INTRATUMORAL ADMINISTRATION OF IMMUNE CELLULAR THERAPEUTICS

 #32
20220387520
2022-12-08

METHODS OF TREATMENT OF BLADDER CANCER BY USING MODIFIED BACILLUS CALMETTE-GUÉRIN

 #33
20220378896
2022-12-01

VACCINE COMPOSITIONS AND METHODS FOR REDUCING TRANSMISSION OF STREPTOCOCCUS PNEUMONIAE

 #34
20220362303
2022-11-17

STABILIZED COLOSTRUM COMPOSITIONS

 #35
20220233671
2022-07-28

Subunit vaccine of contagious caprine pleuropneumonia and preparation method and use thereof

 #36
20220226393
2022-07-21

USE OF PARASITES AND EXTRACELLULAR VESICLES OBTAINED FROM PARASITES IN CANCER TREATMENT

 #37
20220186192
2022-06-16

Vaccinia virus mutants useful for cancer immunotherapy

 #38
20220184197
2022-06-16

Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses

 #39
20220151943
2022-05-19

Vaccine delivery systems using yeast cell wall particles

 #40
20220112566
2022-04-14

Methods and materials for using measles viruses

 #41
20220106364
2022-04-07

COMPLEXES OF CYTOMEGALOVIRUS PROTEINS

 #42
20220105170
2022-04-07

AFRICAN SWINE FEVER VACCINE

 #43
20220096579
2022-03-31

Production and Use of Yeast Extract as a Medical Adjuvant

 #44
20220088182
2022-03-24

Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use

 #45
20220047696
2022-02-17

Anti-coronavirus vaccines

 #46
20210386842
2021-12-16

PRIMING OF AN IMMUNE RESPONSE

 #47
20210353747
2021-11-18

USE OF PLANT EXOSOMES FOR SHOWING MODULATING EFFECTS ON IMMUNE SYSTEM CELLS

 #48
20210353727
2021-11-18

IMMUNOMODULATORY THERAPY FOR TYPE 1 DIABETES MELLITUS AUTOIMMUNITY

 #49
20210347822
2021-11-11

Immunotherapy against several tumors including neuronal and brain tumors

 #50
20210346490
2021-11-11

Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use

 #51
20210338801
2021-11-04

INJECTABLE HYDROGELS FOR CONTROLLED RELEASE OF IMMUNOMODULATORY COMPOUNDS

 #52
20210283234
2021-09-16

ENGINEERED SALMONELLA SEROVAR TYPHIMURIUM STRAINS, COMPOSITIONS THEREOF, AND METHODS OF USE

 #53
20210261614
2021-08-26

Immunotherapy against several tumors including neuronal and brain tumors

 #54
20210253656
2021-08-19

HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use

 #55
20210253637
2021-08-19

Immunotherapy against several tumors including neuronal and brain tumors

 #56
20210252131
2021-08-19

COMPOSITIONS AND METHODS COMPRISING MEASLES VIRUS DEFECTIVE INTERFERING PARTICLES FOR THE PREVENTION OF INFECTIOUS DISEASES

 #57
20210238227
2021-08-05

Immunotherapy against several tumors including neuronal and brain tumors

 #58
20210205469
2021-07-08

Chemically and photochemically initiated cell membrane blebbing to induce cell vesicle production, modifications thereof, and uses thereof

 #59
20210177964
2021-06-17

HEAT-INACTIVATED VACCINIA VIRUS AS A VACCINE IMMUNE ADJUVANT

 #60
20210170018
2021-06-10

Hepatitis C virus immunogenic compositions and methods of use thereof

 #61
20200384103
2020-12-10

SMC COMBINATION THERAPY FOR THE TREATMENT OF CANCER

 #62
20200376115
2020-12-03

Hepatitis B treatment vaccine base on inactivated whole recombinant Hansenula polymorpha cells which expresses HBsAg and HBcAg

 #63
20200368172
2020-11-26

Vaccine delivery systems using yeast cell wall particles

 #64
20200360497
2020-11-19

COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELLS

 #65
20200339959
2020-10-29

Vaccinia virus mutants useful for cancer immunotherapy

 #66
20200316186
2020-10-08

Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses

 #67
20200308659
2020-10-01

Methods and materials for detecting SNPs and administering measles virus

 #68
20200276235
2020-09-03

Combination immunotherapies for treatment of cancer

 #69
20200237903
2020-07-30

Nucleic acid nanostructure platform for antigen presentation and vaccine formulations formed therefrom

 #70
20200197503
2020-06-25

Compositions comprising polysaccharide-protein conjugates and methods of use thereof

 #71
20200109181
2020-04-09

HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use

 #72
20200069596
2020-03-05

Vaccine delivery systems using yeast cell wall particles

 #73
20200009239
2020-01-09

Compositions, methods and therapies for administering antigen peptide

 #74
20190389930
2019-12-26

IMMUNOTHERAPY AGAINST MELANOMA AND OTHER CANCERS

 #75
20190358291
2019-11-28

Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy

 #76
20190351037
2019-11-21

Nicotine nanovaccines and uses thereof

 #77
20190336589
2019-11-07

IMMUNIZING PEPTIDE, METHOD FOR PRODUCING IMMUNIZING PEPTIDE, PHARMACEUTICAL COMPOSITION FOR IMMUNE DISEASE CONTAINING SAME, AND METHOD FOR TREATING IMMUNE DISEASE

 #78
20190322722
2019-10-24

Immunotherapy against melanoma and other cancers

 #79
20190322721
2019-10-24

Immunotherapy against melanoma and other cancers

 #80
20190298764
2019-10-03

Combination immunotherapies for treatment of cancer

 #81
20190290754
2019-09-26

Vaccine composition comprising hepatitis B virus like particle as adjuvant

 #82
20190240162
2019-08-08

Vaccine delivery systems using yeast cell wall particles

 #83
20190231867
2019-08-01

Hepatitis C virus immunogenic compositions and methods of use thereof

 #84
20190216921
2019-07-18

Hepatitis B treatment vaccine on the basis of inactivated, whole recombinant Hansenula polymorpha cells expressing HBsAg

 #85
20190184003
2019-06-20

Compositions and methods comprising measles virus defective interfering particles for the prevention of infectious diseases

 #86
20190177739
2019-06-13

Recombinant influenza virus-like particles (VLPS) produced in transgenic plants

 #87
20190160168
2019-05-30

Immune adjuvant for cancer

 #88
20190062401
2019-02-28

Immunotherapy against melanoma and other cancers

 #89
20190046811
2019-02-14

Miniature wearable laser treatment device

 #90
20190040115
2019-02-07

Immunotherapy against melanoma and other cancers

 #91
20190040114
2019-02-07

Immunotherapy against melanoma and other cancers

 #92
20190040113
2019-02-07

Immunotherapy against melanoma and other cancers

 #93
20190040112
2019-02-07

Immunotherapy against melanoma and other cancers

 #94
20190038742
2019-02-07

Mesenchymal stem cells as vaccine adjuvants and methods for using the same

 #95
20190022018
2019-01-24

Biomembrane, closed structure with biomembrane characteristics or cellular compartment derived from natural sources and/or self-assembly techniques, preparation method and applications thereof

 #96
20190010190
2019-01-10

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS

 #97
20190002513
2019-01-03

Nucleic acids encoding HLA-A24 agonist epitopes of MUC1-C oncoprotein

 #98
20180318409
2018-11-08

CANCER VACCINES

 #99
20180311340
2018-11-01

NEW ADJUVANT AND VACCINE COMPOSITION CONTAINING THE SAME

 #100
20180311339
2018-11-01

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #101
20180305767
2018-10-25

Methods and materials for detecting SNPS and administering measles virus vaccinations

 #102
20180296660
2018-10-18

Immunogenic composition for preventing pneumococcal diseases and preparation method thereof

 #103
20180289789
2018-10-11

Method of eliciting an anti-tumor immune response with controlled delivery of TLR agonists in porous polymerlc devices

 #104
20180193439
2018-07-12

Immunotherapy against melanoma and other cancers

 #105
20180133299
2018-05-17

Compositions, methods and therapies for administering antigen peptide

 #106
20180125955
2018-05-10

PLACENTAL VACCINATION THERAPY FOR CANCER

 #107
20180043008
2018-02-15

RECALL ANTIGEN FOR PROMOTING T-HELPER TYPE 1 RESPONSE

 #108
20180015157
2018-01-18

Attenuated vaccines and methods of making and use thereof

 #109
20170326217
2017-11-16

Immunotherapy against several tumors including neuronal and brain tumors

 #110
20170326216
2017-11-16

Immunotherapy against melanoma and other cancers

 #111
20170320916
2017-11-09

Complexes of cytomegalovirus proteins

 #112
20170296638
2017-10-19

SYNERGISTIC COMPOSITIONS OF IMMUNOSTIMULATING RECONSTITUTED INFLUENZA VIROSOMES WITH IMMUNOPOTENTIATORS AND VACCINES CONTAINING THEM

 #113
20170290898
2017-10-12

PRIMING OF AN IMMUNE RESPONSE

 #114
20170281545
2017-10-05

Immunomodulation using spores and pollen grains

 #115
20170239347
2017-08-24

SMC combination therapy for the treatment of cancer

 #116
20170088848
2017-03-30

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

 #117
20170087233
2017-03-30

Compositions and methods for producing dendritic cells

 #118
20170065532
2017-03-09

Vaccine delivery systems using yeast cell wall particles

 #119
20170007682
2017-01-12

Multivalent stable vaccine composition and methods of making same

 #120
20170000879
2017-01-05

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #121
20160376316
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

 #122
20160376315
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

 #123
20160376314
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

 #124
20160376313
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

 #125
20160376312
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

 #126
20160361397
2016-12-15

Immunomodulatory therapy for type 1 diabetes mellitus autoimmunity

 #127
20160317655
2016-11-03

Traditional chinese medicine mulberry leaves polysaccharide and eucommia polysaccharide immunostimulant and application thereof

 #128
20160296611
2016-10-13

Controlled delivery of TLR3 agonists in structural polymeric devices

 #129
20160287648
2016-10-06

Extract of algae for use as an immunomodulator agent

 #130
20160251406
2016-09-01

HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use

 #131
20160250315
2016-09-01

Human Papilloma virus therapeutic vaccine

 #132
20160220667
2016-08-04

Continuous cell programming devices

 #133
20160193323
2016-07-07

Fowl adenovirus vaccine

 #134
20160159864
2016-06-09

Complexes of cytomegalovirus proteins

 #135
20160158350
2016-06-09

Adjuvant compositions and methods of use

 #136
20160038591
2016-02-11

Method and apparatus for boosting vaccine efficacy

 #137
20160015796
2016-01-21

HER2/Neu cancer vaccine

 #138
20150374806
2015-12-31

Local engineering of the lymph node environment to promote immune tolerance

 #139
20150374774
2015-12-31

Picrorhiza extract for prevention, elimination and treatment of infection diseases

 #140
20150359871
2015-12-17

Immunogenic compositions comprising silicified virus and methods of use

 #141
20150343040
2015-12-03

Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy

 #142
20150335737
2015-11-26

ADJUVANT COMPOSITIONS AND METHODS OF USE

 #143
20150306205
2015-10-29

Vaccine composition for naive subjects

 #144
20150209278
2015-07-30

Process for the production of a submicron oil in water emulsion

 #145
20150196634
2015-07-16

CULTURED MYELOID DENDRITIC CELLS ISOLATED FROM PEYERS PATCHES AND USES THEREOF

 #146
20150191509
2015-07-09

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #147
20150157702
2015-06-11

PNEUMOCOCCAL SEROTYPE 6D

 #148
20150140035
2015-05-21

AUTOLOGOUS BIOLOGICAL CANCER VACCINE

 #149
20150125487
2015-05-07

Attenuated vaccines and methods of making and use thereof

 #150
20150125478
2015-05-07

Immunotherapy against several tumors including neuronal and brain tumors

 #151
20150110828
2015-04-23

Yeast-based therapeutic for chronic hepatitis B infection

 #152
20150086587
2015-03-26

VACCINE ADJUVANT

 #153
20150071876
2015-03-12

Combined measles-malaria vaccine

 #154
20150023997
2015-01-22

Compositions, methods and therapies for administering antigen peptide

 #155
20140302098
2014-10-09

YEAST-BASED VACCINES AS IMMUNOTHERAPY

 #156
20140242152
2014-08-28

Immunogenic compositions and uses thereof

 #157
20140105961
2014-04-17

Immunomodulation using spores and pollen grains

 #158
20140004150
2014-01-02

Vaccine injection, preparation method and use thereof

 #159
20130243723
2013-09-19

Vaccine immunotherapy

 #160
20130142826
2013-06-06

Recombinant influenza virus-like particles (VLPs) produced in transgenic plants expressing hemagglutinin

 #161
20130045235
2013-02-21

Autologous biological cancer vaccine

 #162
20130004456
2013-01-03

Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers

 #163
20120301495
2012-11-29

Antigen peptide and use thereof

 #164
20120148569
2012-06-14

Picrorhiza extract for prevention, elimination and treatment of infection diseases

 #165
20120141517
2012-06-07

Immunotherapy against several tumors including neuronal and brain tumors

 #166
20120121538
2012-05-17

Combined measles-malaria vaccine

 #167
20120107390
2012-05-03

FELINE INFECTIOUS PERITONITIS VACCINE

 #168
20120100182
2012-04-26

Continuous cell programming devices

 #169
20120064035
2012-03-15

Vaccine immunotherapy

 #170
20110305717
2011-12-15

CULTURED MYELOID DENDRITIC CELLS ISOLATED FROM PEYER'S PATCHES AND USES THEREOF

 #171
20110293704
2011-12-01

PRIMING OF AN IMMUNE RESPONSE

 #172
20110287089
2011-11-24

USE OF A SACCHAROMYCES CEREVISIAE MITOCHONDRIAL NUCLEIC ACIDS FRACTION FOR IMMUNE STIMULATION

 #173
20110200610
2011-08-18

Immuno-Modulating Compositions for the Treatment of Immune-Mediated Disorders

 #174
20110135690
2011-06-09

Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer

 #175
20110104198
2011-05-05

Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same

 #176
20110081376
2011-04-07

Method for using inactivated Japanese encephalitis virus particles as adjuvant

 #177
20110076305
2011-03-31

Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins

 #178
20110070267
2011-03-24

PACKAGED VIRUS-LIKE PARTICLES FOR USE AS ADJUVANTS: METHOD OF PREPARATION AND USE

 #179
20110064771
2011-03-17

Plant extracts and uses thereof

 #180
20110002963
2011-01-06

Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers

 #181
20100310656
2010-12-09

Immunotherapy and prevention of autoimmune hepatitis

 #182
20100310604
2010-12-09

RECOMBINANT INFLUENZA VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN TRANSGENIC PLANTS EXPRESSING HEMAGGLUTININ

 #183
20100303841
2010-12-02

ADJUVANT

 #184
20100278945
2010-11-04

PROCESSES OF MAKING NORTH AMERICAN GINSENG FRACTIONS, PRODUCTS CONTAINING THEM, AND USE AS IMMUNOMODULATORS

 #185
20100266534
2010-10-21

Human lymphocyte vaccine adjuvant

 #186
20100216689
2010-08-26

Cytotoxic T cell activator comprising EP4 agonist

 #187
20100209457
2010-08-19

Pneumococcal serotype 6D

 #188
20100196411
2010-08-05

Yeast-Based Vaccine for Inducing an Immune Response

 #189
20100172941
2010-07-08

Adjuvant compositions and methods of use

 #190
20100158946
2010-06-24

Secretory IgA and IgG Antibody Inducer

 #191
20100158931
2010-06-24

Immunotherapy against several tumors including neuronal and brain tumors

 #192
20100136050
2010-06-03

Extracellular Matrix Materials as Vaccine Adjuvants for Diseases Associated with Infectious Pathogens or Toxins

 #193
20100040589
2010-02-18

Novel Compositions and Uses Thereof

 #194
20090304744
2009-12-10

METHODS OF ENHANCING IMMUNE RESPONSE IN THE INTRADERMAL COMPARTMENT AND COMPOUNDS USEFUL THEREOF

 #195
20090263897
2009-10-22

Reishi F3 sub fraction polysaccharides and methods of using same

 #196
20090142833
2009-06-04

Pine Cone Extracts and Uses Thereof

 #197
20090142367
2009-06-04

Yeast-based vaccines as immunotherapy

 #198
20090142366
2009-06-04

Yeast-based vaccines as immunotherapy

 #199
20090098154
2009-04-16

Yeast-based vaccines as immunotherapy

 #200
20080286389
2008-11-20

Processes of making north american ginseng fractions, products containing them, and use as immunomodulators

 #201
20080226682
2008-09-18

Immunoactive Compositions for Improved Oral Delivery of Vaccines and Therapeutic Agents

 #202
20080226673
2008-09-18

SUBUNIT VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS INFECTION

 #203
20080226663
2008-09-18

Pine cone extracts and uses thereof

 #204
20080107665
2008-05-08

Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins

 #205
20080069833
2008-03-20

Yeast-based vaccines as immunotherapy

 #206
20080003239
2008-01-03

Yeast-based vaccine for inducing an immune response

 #207
20070166407
2007-07-19

Plant extracts and uses thereof

 #208
20070128206
2007-06-07

Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters

 #209
20070059389
2007-03-15

Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters

 #210
20060233816
2006-10-19

Use of plant oil-bodies in vaccine delivery systems

 #211
20060115487
2006-06-01

Allogeneic cellular immunotherapy for opportunistic infection

 #212
20060083755
2006-04-20

Vaccine for feline infectious peritonitis

 #213
20060034955
2006-02-16

Pine cone extracts and uses thereof

 #214
20050281832
2005-12-22

Methods of enhancing immune response in the intradermal compartment and compounds useful thereof

 #215
20050232948
2005-10-20

Process for making an adjuvanted vaccine comprising host albumin

 #216
20050202041
2005-09-15

Vaccine adjuvant and making and using the same

 #217
20050196471
2005-09-08

Processes of making north american ginseng fractions, products containing them, and use as immunomodulators

 #218
20050158413
2005-07-21

Pine cone extracts and uses thereof

 #219
20050153004
2005-07-14

Pine cone extracts and uses thereof

 #220
20050106157
2005-05-19

Immunogenic formulations comprising oil bodies

 #221
20050106155
2005-05-19

Solidified tissue immuoadjuvant

 #222
20050042230
2005-02-24

Subunit vaccine against respiratory syncytial virus infection

 #223
15218057
2018-03-20

Herpes simplex virus vaccine compositions and methods of production and use thereof